Target intelligence / Profile preview

Proline rich 23 domain containing 3, pseudogene (PRR23D3P)

Target
PRR23D3P
Molecular classification
Other (Pseudogene)
01

Overview

Proline rich 23 domain containing 3, pseudogene (PRR23D3P) is classified as a pseudogene, meaning it is a segment of DNA that resembles a functional gene but is generally non-coding and does not produce a functional protein[1][3]. Like other pseudogenes, it may theoretically participate in regulatory network functions such as acting as a source for noncoding RNAs or influencing gene expression through RNA-mediated mechanisms, but there are no experimentally validated biological functions or disease associations specifically attributed to PRR23D3P[2][4]. Pseudogenes overall have emerged as potential regulators of gene expression through various mechanisms, including acting as microRNA decoys or sources of small interfering RNAs, but these roles are not established for every specific pseudogene[2]. PRR23D3P is not considered a therapeutic target, nor does it belong to any classical receptor, enzyme, transporter, or signaling protein family, and there are no known drug interactions, biomarkers, or safety concerns directly related to this pseudogene[1][3].

Other names
PRR23D3P
02

Biological functions

Other (No known protein-coding function; general regulatory functions possible for pseudogenes)
03

Disease associations

Other (No specific disease association documented for this pseudogene)

Beyond the preview

Go deeper on Proline rich 23 domain containing 3, pseudogene (PRR23D3P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proline rich 23 domain containing 3, pseudogene (PRR23D3P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call